Skip to main content
SpringerLink
Log in

Frühe radikale Zystektomie bei muskelinvasivem Harnblasenkarzinom

Komplikationen statt Überlebensvorteil und lokaler Rezidivfreiheit

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  1. Vashistha V et al. Int J Radiat Oncol Biol Phys. 2017;97(5):1002–20.

    Article  Google Scholar 

  2. Krause FS et al. Anticancer Res. 2011;31(3):985–90.

    PubMed  Google Scholar 

  3. Kaufman DS et al. Oncologist. 2000;5(6):471–6.

    Article  CAS  Google Scholar 

  4. Kempkensteffen C. Klinikarzt. 2017;46(09):444–8.

    Article  Google Scholar 

  5. Ploussard G et al. Eur Urol. 2014;66(1):120–37.

    Article  CAS  Google Scholar 

  6. Rödel C et al. J Clin Oncol. 2002;20(14):3061–71.

    Article  Google Scholar 

  7. Weiss C et al. Int J Radiat Oncol Biol Phys. 2008;70(5):1502–6.

    Article  Google Scholar 

  8. Erstpubliziert in Strahlenther Onkol. 2017;194(4):358-59.

  9. Vashistha V et al. Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2017;97(5):1002–20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radio-Onkologie, Ruhr-Universität Bochum, Herne, Herne, Deutschland

    Irenäus A. Adamietz

Authors
  1. Irenäus A. Adamietz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irenäus A. Adamietz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adamietz, I.A. Komplikationen statt Überlebensvorteil und lokaler Rezidivfreiheit. Info Onkol. 21, 35–37 (2018). https://doi.org/10.1007/s15004-018-6096-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-018-6096-2

Search

Navigation